Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | URGN | AUPH |
|---|---|---|
| Price | $42.78 | $15.72 |
| Change today | ▲ 3.33% | ▼ 0.69% |
| Market cap | $2.09B | $2.09B |
| Return, 3 months | +13.3% | -3.1% |
| Return, year to date | +82.7% | -1.4% |
| Return, 1 year | +150.9% | +38.9% |
| P/E (TTM) | -21.7 | 6.9 |
| P/B | -15.8 | 3.4 |
| P/E percentile vs own 5y | 2nd | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +20.4% |
| Net profit growth (YoY) | – | +4,893.1% |
| Gross margin | – | 88.5% |
| Operating margin | – | 37.6% |
| Net margin | – | 101.5% |
| Return on equity | – | – |
| Analyst target vs. price | +40.7% | +20.9% |
| Analyst buy share | 80% | 100% |
| RSI (14) | 51 | 40 |
| 30-day volatility | 33.8% | 22.0% |
| Max drawdown, 1 year | -42.2% | -21.8% |
| Trend read | Leaning bullish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
